CVCarla Valente

Carla Valente

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Carla Valente has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Pneumomediastinum “through the shoulder”: report of a rare case

    by Catarina Cascais-Costa, Carla Valente, Pedro Goncalo Ferreira

  • Open Access

    Patients’ perspectives on exposure to environmental contaminants: a missing piece in pulmonary rehabilitation?

    by Sara Souto‐Miranda, Sara Dias, Carla Valente, Célia Freitas, Ana Margarida Sousa, Ana C. A. Sousa, Alda Marques

    Chronic obstructive pulmonary disease (COPD) is influenced by environmental factors, such as indoor/outdoor contaminants. However, patients’ views on environmental exposure are little-known and this is an often-neglected topic in psychoeducational sessions in pulmonary rehabilitation (PR). We explored the views of patients with COPD about indoor/outdoor environment and its influence on their health and the impact of an environmental educational session within PR, on their daily living. Focus groups were conducted before and after community-based PR. An educational session was designed and included in PR after the first focus group. Data were analysed with thematic analysis. Four focus groups were conducted with 31 patients with COPD (71±8y; 74%male; FEV1 48±17pp; 45% GOLD2; 58% GOLDB). Prior to PR, 3 themes emerged: 1) “just seeing the tip of the iceberg” since some awareness existed but a feeling of probably not knowing the real impact was shared; 2) “feeling resigned” where patients acknowledged having poor strategies to avoid contaminants and felt there was little they could do; and 3) “willingness to learn” as they reported the need for an educational session to improve their knowledge on environmental exposures. After PR, 2 themes were found: 1) “gratefulness” where patients shared that the session was helpful for themselves and significant others; and 2) “personal change”, where patients expressed how their behaviour changed towards more health-enhancing strategies to deal with contaminants. Environmental education within PR is valued by patients and leads to specific behaviour changes to deal with contaminants’ exposure. Further attention to this topic is warranted.

  • Open Access

    Minimal Clinically Important Differences for Patient-Reported Outcome Measures of Cough and Sputum in Patients with COPD

    by Patrícia Rebelo, Ana Oliveira, Cátia Paixão, Carla Valente, Lília Andrade, Alda Marques

    Background: Cough and sputum are highly prevalent in patients with chronic obstructive pulmonary disease (COPD). Pulmonary rehabilitation (PR) has shown to be effective in managing these symptoms. However, the interpretation of the magnitude of PR effects is hindered by the lack of minimal clinically important differences (MCIDs). Purpose: This study established MCIDs for the Leicester cough questionnaire (LCQ) and the cough and sputum assessment questionnaire (CASA-Q), in patients with COPD after PR. Patients and Methods: An observational prospective study was conducted in patients with COPD who participated in a 12-weeks community-based PR program. Anchor- (mean change, receiver operating characteristic curves and linear regression analysis) and distribution-based methods [0.5*standard deviation; standard error of measurement (SEM); 1.96*SEM; minimal detectable change and effect size] were used to compute the MCIDs. The anchors used were: i) patients and physiotherapists global rating of change scale, ii) COPD assessment test, iii) St. George’s respiratory questionnaire and iv) occurrence of an exacerbation during PR. Pooled MCIDs were computed using the arithmetic weighted mean (2/3 for anchor- and 1/3 for distribution-based methods). Results: Forty-nine patients with COPD (81.6% male, 69.8± 7.4years, FEV1 50.4± 19.4%predicted) were used in the analysis. The pooled MCIDs were 1.3 for LCQ and for CASA-Q domains were: 10.6 - cough symptoms; 10.1 - cough impact; 9.5 - sputum symptoms and 7.8 - sputum impact. Conclusion: The MCIDs found in this study are potential estimates to interpret PR effects on cough and sputum, and may contribute to guide interventions.


  • Can the five repetition sit-to-stand test discriminate inpatients and outpatients with acute exacerbations of COPD?

    by Ana Machado, Ana Oliveira, Marta Vieira, Carla Valente, Filipa Januário, Alda Sofia Pires De Dias Marques

    The five repetition sit-to-stand test (5STS) is a simple and validated functional test, suitable to be performed in different settings, that has been related with mortality in chronic obstructive pulmonary disease (COPD). Yet, its relationship with the need for hospitalisation is unknown. This study explored the 5STS ability to discriminate between hospitalised and non-hospitalised patients at the onset of an acute exacerbation of COPD (AECOPD). Patients with AECOPD visiting the urgency ward of 2 hospitals were recruited. Clinicians defined the need for hospitalisation based on their best judgment. The 5STS was completed within 48h of the AECOPD onset. Receiver operating characteristic analysis was performed and the area under the curve (AUC) was calculated. 47 patients (92% male, 69±7yrs, FEV150±20%predicted) participated. Age, gender, FEV1, body mass index and quadriceps muscle strength were not different between inpatients and outpatients. 5STS showed good ability to discriminate between inpatients and outpatients (AUC=0.73; 95%CI 0.59-0.88), with a sensitivity of 75% and specificity of 53% for a cut-off of 13.7s (Fig. 1). 5STS can accurately discriminate between inpatients and outpatients with AECOPD. A cut-off of 13.7s may be used to differentiate these patients. Results also emphasise the need to improve patients’ functionality during hospitalisation. Studies with larger samples are needed.


  • Airway Microbiota diversity and composition correlates with severity of Chronic Obstructive Pulmonary Disease (COPD)

    by Sara Dias, Filipa Machado, Carla Valente, Lilia Andrade, Alda Marques, Ana Sousa

    COPD occurrence is mediated by immune response, environmental factors and microbial dysbiosis. Airway microbiota has been found to be different between healthy people and patients with COPD and these differences could influence disease severity. But, its clinical implications are still unclear. Here, we have explored the airway microbiota of patients with COPD as well as its relations with specific clinical parameters. 40 patients (35?, 67±9y, FEV1pp 33±7, GOLD III-26, IV-14) and 40 healthy controls (34?, 67±12y, FEV1pp 101±19) were recruited and sociodemographic, anthropometric and clinical data were collected. Saliva microbiota was characterised by 16S rRNA sequencing and analysed using Qiime2 pipeline. Significant differences in airway microbiota composition between patients and healthy people were observed (Fig 1). The microbiota of patients with worse clinical parameters, like lower FEV1pp and SpO2, or with higher number of exacerbations and hospitalisations, clustered separately from less severe. Loss of microbiota diversity correlated with age in patients, but not in healthy people, raising the hypothesis of the cumulative use of antibiotics (by patients) contributing to dysbiosis. The association between microbiota composition and clinical parameters supports its contribution to COPD trajectory. Future studies should focus on remodelling patients’ dysbiotic microbiotas towards healthier ensembles aiming at preventing disease decline.

  • Open Access

    Assessment of Inhalation Technique in Clinical and Functional Control of Asthma and Chronic Obstructive Pulmonary Disease

    by Tiago Maricoto, Luís Vaz Rodrigues, Gilberto Teixeira, Carla Valente, Lília Andrade, Alcina Saraiva

    Introduction: Chronic obstructive pulmonary disease and asthma affect almost 300 million individuals. Inhaled therapy is often associated with technical errors reducing efficacy and compliance.Objective: To evaluate the inhalation technique and its relation with clinical and functional control in asthma and chronic obstructive pulmonary disease.Material and Methods: Analytical cross-sectional study including patients with asthma and chronic obstructive pulmonary disease treated with any type of inhaler device. Demographic data and inquiry about previous teaching of inhalation technique were collected in all participants. Inhalation technique was evaluated in: Step 1 - device activation; Step 2 - previous expiration; Step 3 - inspiration; Step 4 - end inspiratory pause. Clinical control was assessed from the questionnaires Asthma Control Test, Control of Allergic Rhinitis and Asthma Test, modified Medical Research Council and Chronic Obstructive Pulmonary Disease Assessment Test. Spirometric evaluation was performed in all participants.Results: From a total of 62 subjects, 74.19% made at least one error, mainly during step 2 (53.2%). Previous education on inhalation technique was associated with lower number of errors (p = 0.014). There was no association between number of errors and age (p = 0.321), years of diagnosis (p = 0.119) or spirometric evaluation (p > 0.05). In asthma an association was found between number of errors and Asthma Control Test (p = 0.032) and Control of Allergic Rhinitis and Asthma Test (p = 0.008).Discussion and Conclusion: Teaching inhalation technique has a positive impact on its future performance. Most patients make mistakes, affecting clinical control in asthma, although in chronic obstructive pulmonary isease no relation was found. This is an ongoing work that aims to reevaluate inhalation technique after patients’ education and its further impact.